NCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
Clinical Trials
14 trialsNCT03879629 2025-11-20
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure
Mayo Clinic
Phase 2 Active not recruiting
NCT03418961 2025-10-08
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Phase 3 Recruiting
NCT02717507 2025-04-23
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Children's Oncology Group
Phase 2 Completed
NCT06836778 2025-02-20
Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices
Institute of Liver and Biliary Sciences, India
Phase NA Not yet recruiting
NCT06594744 2025-02-13
P-HCC-CVL
Taipei Veterans General Hospital, Taiwan
Phase 4 Recruiting
NCT06643221 2024-10-16
Allo-X
University of Arizona
Phase EARLY_PHASE1 Recruiting
NCT04939883 2024-06-28
CardioTox
Hospital Sirio-Libanes
Phase 4 Unknown
NCT03980249 2021-04-12
Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
West Virginia University
Phase EARLY_PHASE1 Withdrawn
NCT01009918 2021-03-30
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
University of South Florida
Phase 2 Completed
NCT02944201 2021-02-21
Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate
Montefiore Medical Center
Phase 2 Unknown
NCT01724450 2018-02-05
Ceccy
University of Sao Paulo
Phase 3 Completed
NCT01659346 2017-11-17
Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.
Institute of Liver and Biliary Sciences, India
Phase NA Withdrawn
NCT01110824 2013-11-15
OVERCOME
Hospital Clinic of Barcelona
Phase 3 Completed